156 related articles for article (PubMed ID: 38238510)
1. The antihypertensive action of C-phycocyanin is related to the prevention of angiotensin II-caused vascular dysfunction in chronic kidney disease.
Tapia-Martínez JA; Centurión D; Franco-Colin M; Sánchez-López A; Beltran-Ornelas JH; Silva-Velasco DL; Franco PR; Blas-Valdivia V; Cano-Europa E
Hypertens Res; 2024 Apr; 47(4):1024-1032. PubMed ID: 38238510
[TBL] [Abstract][Full Text] [Related]
2. The Nutraceutical Antihypertensive Action of C-Phycocyanin in Chronic Kidney Disease Is Related to the Prevention of Endothelial Dysfunction.
Rojas-Franco P; Garcia-Pliego E; Vite-Aquino AG; Franco-Colin M; Serrano-Contreras JI; Paniagua-Castro N; Gallardo-Casas CA; Blas-Valdivia V; Cano-Europa E
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35406077
[TBL] [Abstract][Full Text] [Related]
3. The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.
García Trejo EMÁ; Arellano Buendía AS; Sánchez Reyes O; García Arroyo FE; Arguello García R; Loredo Mendoza ML; Tapia E; Sánchez Lozada LG; Osorio Alonso H
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926934
[TBL] [Abstract][Full Text] [Related]
4. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
5. NaHS restores the vascular alterations in the renin-angiotensin system induced by hyperglycemia in rats.
Silva-Velasco DL; Beltran-Ornelas JH; Tapia-Martínez J; Sánchez-López A; de la Cruz SH; Cervantes-Pérez LG; Del Valle-Mondragón L; Sánchez-Mendoza A; Centurión D
Peptides; 2023 Jun; 164():171001. PubMed ID: 36990388
[TBL] [Abstract][Full Text] [Related]
6. Changes in protein and gene expression of angiotensin II receptors (AT1 and AT2) in aorta of diabetic and hypertensive rats.
Romero-Nava R; Rodriguez JE; Reséndiz-Albor AA; Sánchez-Muñoz F; Ruiz-Hernandéz A; Huang F; Hong E; Villafaña S
Clin Exp Hypertens; 2016; 38(1):56-62. PubMed ID: 26268856
[TBL] [Abstract][Full Text] [Related]
7. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease.
Aminzadeh MA; Reisman SA; Vaziri ND; Shelkovnikov S; Farzaneh SH; Khazaeli M; Meyer CJ
Redox Biol; 2013; 1(1):527-31. PubMed ID: 24363993
[TBL] [Abstract][Full Text] [Related]
8. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
Zhuo J; Ohishi M; Mendelsohn FA
Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
[TBL] [Abstract][Full Text] [Related]
9. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
[TBL] [Abstract][Full Text] [Related]
10. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease.
Beraldo JI; Benetti A; Borges-Júnior FA; Arruda-Junior DF; Martins FL; Jensen L; Dariolli R; Shimizu MH; Seguro AC; Luchi WM; Girardi ACC
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010001
[TBL] [Abstract][Full Text] [Related]
13. Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats.
Li JS; Touyz RM; Schiffrin EL
Hypertension; 1998 Jan; 31(1 Pt 2):487-92. PubMed ID: 9453350
[TBL] [Abstract][Full Text] [Related]
14. Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade.
Bonnet F; Candido R; Carey RM; Casley D; Russo LM; Osicka TM; Cooper ME; Cao Z
J Hypertens; 2002 Aug; 20(8):1615-24. PubMed ID: 12172324
[TBL] [Abstract][Full Text] [Related]
15. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats.
Gigante B; Piras O; De Paolis P; Porcellini A; Natale A; Volpe M
J Hypertens; 1998 Dec; 16(12 Pt 2):2039-43. PubMed ID: 9886894
[TBL] [Abstract][Full Text] [Related]
16. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y
Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
[TBL] [Abstract][Full Text] [Related]
17. Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.
Wagenaar GT; Laghmani el H; Fidder M; Sengers RM; de Visser YP; de Vries L; Rink R; Roks AJ; Folkerts G; Walther FJ
Am J Physiol Lung Cell Mol Physiol; 2013 Sep; 305(5):L341-51. PubMed ID: 23812633
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
Uhlenius N; Miettinen A; Vuolteenaho O; Tikkanen I
Kidney Blood Press Res; 2002; 25(2):71-9. PubMed ID: 12077487
[TBL] [Abstract][Full Text] [Related]
19. Cross-Talk between CB
Mińczuk K; Schlicker E; Malinowska B
Cells; 2022 May; 11(9):. PubMed ID: 35563848
[TBL] [Abstract][Full Text] [Related]
20. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
